---
title: "Moleculin Biotech (MBRX.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/MBRX.US/norm.md"
symbol: "MBRX.US"
name: "Moleculin Biotech"
parent: "https://longbridge.com/zh-CN/quote/MBRX.US.md"
datetime: "2026-05-19T23:13:05.260Z"
locales:
  - [en](https://longbridge.com/en/quote/MBRX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MBRX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MBRX.US/norm.md)
---

# Moleculin Biotech (MBRX.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -3.54 | 6.90 | -17.02 | -27.28 | -17.22 |
| ROE | -387.16% | -1037.30% | 596.13% | 1940.42% | -855.14% |
| 营业收入 | - | - | - | - | - |
| 净利润 | -14.61M | 15.45M | -25.40M | -17.28M | -6.44M |
| 营业利润 | -7.87M | -7.53M | -5.91M | -5.72M | -5.94M |
| 毛利率 | - | - | - | - | - |
| 净利率 | - | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 23.36M | 22.13M | 20.35M | 21.59M | 21.01M |
| 权益乘数 | 1.54 | 1.47 | -0.7561 | -3.01 | 500.31 |
| 每股净资产 | 2.85 | 4.69 | -13.60 | -5.93 | 0.0743 |
| 资产周转率 | - | - | - | - | - |
| 现金及短投 | 10.32M | 8.88M | 6.70M | 7.56M | 7.72M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 354000.00 | 392000.00 | 420000.00 | 469000.00 | 525000.00 |
| 净债务 | -10.13M | -8.52M | -6.31M | -7.14M | -7.27M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -6.11M | -5.37M | -7.22M | -5.58M | -4.56M |
| 投资现金流 | - | - | - | - | - |
| 融资现金流 | 7.61M | 7.49M | 6.38M | 5.42M | 8.00M |
| 自由现金流 | -3.50M | -2.61M | -5.26M | -2.01M | -2.37M |
| 现金流充裕率 | - | - | - | - | - |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | - | - | - | - | - |